3-Minute video aims to boost latent TB treatment completion

NCT ID NCT05412212

Completed Knowledge-focused Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests whether a 3-minute educational video can help more people complete their treatment for latent tuberculosis (LTBI). About 1,898 adults at Kaiser Permanente Southern California are randomly assigned to receive the video or standard care. The main goal is to see if the video increases the number of patients who finish their medication within a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 3-minute educational video
What this could lead to: If it works, this low-cost video could help more people complete latent TB treatment, reducing the risk of developing active TB.
What could go wrong: This is a behavioral intervention, not a new drug. The effect may be small, and results from one healthcare system may not apply everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATENT TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

latent tuberculosis infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LATENT TUBERCULOSIS

Contacts and locations

Locations

Kaiser Permanente Southern California Department of Research and Evaluation

Pasadena, California, 91103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.